At Close: 4:00 PM
Frequently Asked Questions
What is the current Immunic, Inc. (IMUX) stock price?
Immunic, Inc. (NASDAQ: IMUX) stock price is $1.36 as of the last check on Monday, December 5. During the trading session, IMUX stock reached the peak price of $1.42 while $1.342 was the lowest point it dropped to. The percentage change in IMUX stock occurred in the recent session was 0% while the dollar amount for the price change in IMUX stock was $0.00.
IMUX's industry and sector of operation?
The NASDAQ listed IMUX is part of Biotechnology industry that operates in the broader Health Care sector. Immunic, Inc. , a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases.
Who are the executives of IMUX?
Dr. Duane D. Nash M.B.A., M.D., J.D., M.B.A
Dr. Daniel Vitt
CEO, Pres & Director
Mr. Glenn Whaley CPA
Chief Financial Officer
Dr. Andreas Muehler M.D., Ph.D.
Chief Medical Officer
How IMUX did perform over past 52-week?
IMUX's closing price is 0.022900833% higher than its 52-week low of $1.31 where as its distance from 52-week high of $14.5 is -0.9075862%.
How many employees does IMUX have?
Number of IMUX employees currently stands at 55. IMUX operates from 1200 Avenue of the Americas, Suite 200, New York, NY 10036, United States.
Link for IMUX official website?
Official Website of IMUX is: https://www.immunic-therapeutics.com
How do I contact IMUX?
How many shares of IMUX are traded daily?
IMUX stock volume for the day was 8,188 shares while in the previous session number of IMUX shares traded was 440,900. The average number of IMUX shares traded daily for last 3 months was 3.79 Million.
What is the market cap of IMUX currently?
The market value of IMUX currently stands at $53 Million with its latest stock price at $1.36 and 39.26 Million of its shares outstanding.